Effect of focal mild hypothermia on expression of MMP-9, TIMP-1, Tau-1 and β-APP in rats with cerebral ischaemia/reperfusion injury

Following stroke, hypothermia is reported to reduce both cellular and extracellular damage. This study aimed to examine the effects of focal mild hypothermia on proteins associated with both extracellular (matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of MMP-9 (TIMP-1)) and cellular damage...

Full description

Saved in:
Bibliographic Details
Published inBrain injury Vol. 27; no. 10; p. 1190
Main Authors Zhao, Jing-Kun, Guan, Fu-Lin, Duan, Shu-Rong, Zhao, Ji-Wei, Sun, Rui-Hong, Zhang, Li-Ming, Wang, De-Sheng
Format Journal Article
LanguageEnglish
Published England 01.09.2013
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Following stroke, hypothermia is reported to reduce both cellular and extracellular damage. This study aimed to examine the effects of focal mild hypothermia on proteins associated with both extracellular (matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of MMP-9 (TIMP-1)) and cellular damage (Tau-1 and β-amyloid precursor protein (β-APP)) to characterize the protective effects of hypothermia. Male Wistar rats received ischaemic damage using a transient, focal ischaemia/reperfusion model. Afterwards, one group (HT) received 6 hours of focal mild hypothermia (33 °C) applied to the head, while another remained at normal temperature (NT). The brains were collected at 6, 12, 24, 48 and 72 hours after hypothermia to measure infarct volume ratio and to detect cells immunopositive for MMP-9, TIMP-1, Tau-1 and β-APP, while neurological deficits were examined separately after 2 weeks. Focal mild hypothermia had no effect on infarct volume ratio but expression of MMP-9, TIMP-1 Tau-1 and β-APP was decreased. Furthermore, neurological function in the HT group was better than in the NT group. Focal mild hypothermia has protective effects on cerebral ischaemia-reperfusion injury characterized by decreased expression of MMP-9, TIMP-1, Tau-1 and β-APP, along with improvement of neurological function despite no changes in infarct volume.
ISSN:1362-301X
DOI:10.3109/02699052.2013.804206